This review discusses how the bronchial artery circulation is interrupted following lung transplantation and what may be the long-term complications of compromising systemic blood flow to allograft airways.
Introduction
Lung transplantation is an effective treatment for endstage pulmonary parenchymal and vascular disease. However, long-term survival following this procedure remains suboptimal compared with other solid organs owing to the development of chronic rejection or bronchiolitis obliterans syndrome (BOS). BOS develops in 30-50% of lung transplant recipients at 3-5 years following transplantation and manifests pathologically as fibro-obliteration of the small airways. The increased incidence of chronic rejection has been suggested to be related to the fact that lung transplants are the only solid organ allografts that do not routinely undergo direct systemic arterial reconnection at the time of surgery [1 ] . Under normal settings, the airways are supplied by a dual circulation derived from the bronchial arteries and the pulmonary artery. Prior to transplantation, approximately 50% of the blood flow to airways normally comes from the bronchial arteries and approximately 50% from the poorly oxygenated pulmonary artery circulation [2] . Because only the pulmonary artery circulation is surgically restored at the time of transplantation, the bronchial anastomosis and distal airways may be exquisitely susceptible to further ischemia and hypoxic injury. In fact, early attempts at the lung transplantation were complicated by the development of airway dehiscence or stenosis. Improvements in surgical technique including the use of omental wrapping or telescoping of the bronchial anastomosis led to improved anastomotic healing and the incidence of airway dehiscence decreased. Bronchial artery revascularization at the time of lung transplantation was originally touted as a technique to preserve the anastomosis site by limiting tissue ischemia in the early 1990s. However, given the improvement in airway healing with the anastomotic surgical techniques, reconnection of the bronchial arteries, at the time of transplantation, was deemed unnecessary [3] . This review will address the anatomy of the bronchial artery circulation, the fate of bronchial arteries following lung transplantation, the link between hypoxia, ischemia and fibrosis, and, finally, the rationale for considering reinstitution of bronchial artery revascularization at the time of transplantation.
Normal bronchial artery anatomy
The bronchial artery circulation is part of the systemic circulation, normally arising as two main vessels entering the airways at the hila, and originating from either the aorta, the intercostals arteries or, rarely, the internal mammary and coronary arteries [4 ] . This circulation has been highly conserved through mammalian evolution, but its function has not been clearly established [5] . The bronchial artery blood vessels form a plexus with communicating vessels that empty into pulmonary veins to form the bronchopulmonary circulation in normal airways. Bronchial arteries supply the bronchial mucosa as well as the visceral pleura. The fate of airway microvasculature following lung transplantation Currently, despite the feasibility of performing bronchial artery revascularization at the time of lung transplantation, the bronchial artery circulation is not routinely reattached under current surgical practice. Preclinical canine studies have demonstrated that the bronchial artery circulation can be slowly restored de novo (i.e. by secondary intention) following transplantation through the process of angiogenesis [6, 7] . Similarly, heart-lung transplant recipients occasionally develop systemic collateral circulation to the airways from the coronary arteries [8, 9] . The de novo regrowth of bronchial arteries had not been assessed systematically in clinical lung transplantation until recently. Dhillon et al.
[1 ] reported on the sources of airway perfusion and on the state of airway oxygenation in single lung transplant recipients. They first demonstrated by ventilation perfusion imaging that pulmonary blood flow was preferentially shunted from the native to the transplanted lung by 3 months [73% (Tp) vs. 27% (native)], and tha this shunting was still evident by 12 months [78% (Tp) vs. 22% (native)]. However, as determined by measurement of airway oxygenation, transplanted airways remained relatively hypoxic compared with airways in native (diseased) lungs and to airways in normal lungs. Further, CT-angiography studies failed to demonstrate an identifiable bronchial artery circulation beyond the anastomotic level within the transplanted lung. The authors concluded that airway hypoxia might be due, in part, to the failure of bronchial arteries to regrow into the lung following transplantation. Thus, even though preclinical models and isolated cases of heart-lung transplant patients have demonstrated de-novo growth of bronchial arteries into airways by second intention, this appears to be a limited and very late phenomena in lung transplant recipients; if this regrowth can be said to occur routinely at all as the only patient showing evidence of bronchial artery regrowth was more than a year out posttransplant. This review will discuss how the failure to restore the bronchial artery circulation by primary intention may ultimately have important implications for the overall function and health of the distal airways.
Interest in the development of airway revascularization following lung transplantation increased after the report of recent investigations into the potential role of the loss of airway vascularity in the development of BOS. Autopsy studies from Luckraz et al. [10, 11] demonstrated a significant loss of microvasculature in nonobliterated small airways from BOS lungs; suggesting that microvascular loss and airway ischemia is a preceding condition to airway fibrosis. Lung transplant patients who died without BOS had a normal number of blood vessels around their airways. However, in those patients who died with BOS, otherwise normal airways adjacent to BOS airways (i.e. pre-BOS airways) exhibited a significantly diminished microvasculature whereas in adjacent lung with BOS, there were increased numbers of small caliber blood vessels. The cause for the loss of vascularity in pre-BOS airways could be due to immune-mediated injury and inflammation whereas the increase in vascularity in BOS airways could represent angiogenesis in the response to such injury. Loss of a functional microvasculature in an orthotopic airway transplant model identified those grafts that could not be rescued from fibrosis with immunotherapy [12 ] . This preclinical study suggested that steroid-resistance in chronic rejection may be attributed, in part, to the destruction of the microvasculature in grafts. This study also demonstrated how acute rejection could culminate in profound airway hypoxia as graft vessels are destroyed, inflammation becomes significant and airways become transiently ischemic. These concepts describing the dynamic changes of the airway vasculature in lung transplant recipients are summarized in Fig. 1 .
Hypoxia, ischemia and airway fibroproliferation
The mechanisms by which hypoxia and ischemia facilitate postinflammatory fibrosis are not established but the clustering of hypoxia, ischemia, inflammation and fibrosis is routinely observed in several clinical situations such as normal skin wound healing [13 ] and chronic kidney diseases [14 ] . In pulmonary fibrosis in mice and in humans, microarray data sets demonstrate hypoxic signaling to be among the most statistically important dysregulated pathways [15] [16] [17] . In-vitro studies have demonstrated profibrotic phenotypic changes in fibroblasts as a response to hypoxia [18, 19] . Epithelial and endothelial cells can undergo mesenchymal transition (EMT) under ischemia to become a source of activated fibroblasts [20] . Hypoxia likely directly contributes to the progression of fibrosis by increasing the release of major extracellular matrix proteins [21 ] . Transforming growth factor-b2-induced fibrosis is associated with intense vasoconstriction and tissue hypoxia [22] . Finally, loss of a functional microcirculation should interfere with the effective tissue delivery of systemic immunosuppression. Which of the earlier-mentioned phenomena (i.e. activated fibroblasts, EMT, release of matrix proteins, or altered drug delivery) contributes most significantly to airway fibrosis is not known, but it is clear that inflamed tissue subject to low pO 2 and ischemia appears to be at increased risk for fibrotic remodeling.
Potential benefits of restoring the bronchial artery circulation at the time of lung transplantation
As noted before, only the pulmonary artery circulation is restored at the time of transplantation rejection and the highly oxygenated bronchial artery circulation is sacrificed in all lung transplant recipients. Therefore, following lung transplantation, the low O 2 pulmonary artery circulation is the major source of blood and microvasculature for transplanted lungs. Exclusion of this rearterialization step may have more distant effects not evident in the early postoperative clinical course. Preclinical and preliminary clinical studies demonstrate that performing bronchial artery revascularization at the time of transplantation improves tissue perfusion with more highly oxygenated blood [23, 24] , is durable [25] , is associated with less epithelial metaplasia [26] , is protective of pulmonary endothelium and type II pneumocytes [27] , and may postpone the development of BOS, whereas improving patient survival [28] .
There are other sequelae, beyond hypoxia, which may occur following the loss of the bronchial artery circulation and could contribute to airway disease. Restoration of the bronchial artery circulation at the time of lung transplantation would theoretically benefit these putative deficits as well. These deficits include the loss of airway nutrition, altered lymphatic flow, decreased airway-lining fluid, attenuated innate immune defenses, diminished clearance of small particles and reduced control of airway temperature and humidity [4 ,29] . The bronchial circulation is responsible for the formation of the epitheliallining fluid, which plays a role in the local defenses against inhaled irritants and foreign substances. In contrast to the pulmonary circulation, bronchial artery vascular transudates appear to contribute to lymphatic flow [30] . What happens to lymphatic flow in the absence of this bronchial artery contribution is not known. A functional bronchial artery circulation is required for the maintenance of normal mucociliary transport [31] . Interrupting the bronchial artery likely leads to interference with absorbing and clearing airway particles [30] . Finally, the airway mucosa responds to the cooling of airways Bronchial blood supply after lung transplantation Nicolls and Zamora 565 following the inhalation of cold air by increasing bronchial blood flow and by doing this, improves heat and water transfer from the air. This same circulation is capable of conserving moisture in dry environments such that only one-tenth of the normal humidity is exhaled [31] . Therefore, the loss of a bronchial circulation could negatively impact the regulation of airway temperature and humidity. In summary, whereas exaggerated tissue hypoxia with inflammation could occur in the absence of a bronchial artery circulation, there are several other functions normally performed by the bronchial artery circulation that could also contribute to tissue fibrosis. The potential benefits of restoring the bronchial artery circulation at the time of lung transplantation could limit the loss of these normal functions and, in so doing, promote the health of the transplant.
Conclusion
Chronic airway hypoxia and ischemia owing to vascular interruption or injury may be a significant risk factor for airway fibrosis following transplantation [24, 32, 33] . The bronchial artery normally performs numerous functions, which are likely lost in the absence of reconnection. Emerging preclinical and clinical evidence suggests that bronchial artery revascularization performed at the time of lung transplantation may have graft-protective effects, which will make patients less susceptible to the development of BOS. A multicenter trial now appears to be warranted to study this question.
